Trump administration unlawfully terminated grants from Harvard, federal judge rules

Population-based cancer surveillance is a national treasure at risk

There is a silent crisis in cancer research that underpins nearly all aspects of the work we do to combat this disease.

September 26, 2025

By Eric B. Durbin, Karen L. Knight, Betsy Kohler and Sarah Nash

Earlier diagnosis, better outcomes: Telemedicine has found a home in oncology

We are rapidly approaching the Sept. 30 planned expiration of telemedicine coverage under Medicaid. Letting this authorization expire is short-sighted. As an oncologist, I believe there are multiple compelling, non-pandemic reasons for telemedicine to remain a permanent fixture in cancer care.

Bhattacharya: New grant review criterion is “not political”

NIH’s new “unified grant funding policy,” is “not political,” NIH Director Jay Bhattacharya said during his remarks at Research!America’s annual National Health Research Forum Sept. 17.

Break Through Cancer launches a $15M multi-institute pediatric osteosarcoma research initiative

Break Through Cancer has launched the Defying Osteosarcoma TeamLab, an initiative that brings together more than 20 researchers from eight institutions in a coordinated, multi-year effort focused on improving pediatric osteosarcoma care.

September 26, 2025

Vol.51 No.35

Funding Opportunities

Project Purple announces research grant to sustain pancreatic cancer studies that have been disrupted by federal funding policy changes

Project Purple, a national nonprofit dedicated to empowering the fight against pancreatic cancer, is launching the Pancreatic Cancer Research Recovery Support Grant. The initiative provides up to two years of bridge or rescue funding for promising pancreatic cancer research projects that were disrupted due to administrative funding policy changes at major federal agencies such as the NIH, the Department of Defense, or the National Science Foundation.

September 26, 2025

Vol.51 No.35

NCI is “really, really sturdy” and won’t break, former directors Ned Sharpless and Kim Rathmell say at UNC Lineberger symposium

Grants are flowing out of NCI again to beat the fiscal-year end deadline and some cancer researchers are starting to feel cautiously optimistic about the future.

September 19, 2025

Vol.51 No.34

By Paul Goldberg

Trump administration unlawfully terminated grants from Harvard, federal judge rules

YOU MAY BE INTERESTED IN

Population-based cancer surveillance is a national treasure at risk

Earlier diagnosis, better outcomes: Telemedicine has found a home in oncology

Bhattacharya: New grant review criterion is “not political”

Break Through Cancer launches a $15M multi-institute pediatric osteosarcoma research initiative

Project Purple announces research grant to sustain pancreatic cancer studies that have been disrupted by federal funding policy changes

NCI is “really, really sturdy” and won’t break, former directors Ned Sharpless and Kim Rathmell say at UNC Lineberger symposium

Renew today!

Subscriber content

Never miss an issue!

Login